Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 298.21B, Merck(MRK) trades at $120.53. The stock has a price-to-earnings ratio of 33.52 and currently yields dividends of 2.8%.
As of 2026-06-11, Merck(MRK) stock has fluctuated between $118.91 and $122.71. The current price stands at $120.53, placing the stock +1.4% above today's low and -1.8% off the high.
The Merck(MRK)'s current trading volume is 13.04M, compared to an average daily volume of 11.6M.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.
MRK News
Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influenc...
...
(RTTNews) - Merck Animal Health, a division of Merck & Co. (MRK), on Thursday announced a definitive agreement to acquire TARGAN, a privately held developer of...
Analyst ratings
70%
of 30 ratingsMore MRK News
Merck (MRK) division Merck Animal Health has signed a definitive agreement to acquire Targan, a privately held innovator in developing and commercializing biode...
Advertisement Merck stock snapshot after recent trading move Merck (MRK) moved slightly lower in the latest trading session, with the stock closing at US$119....
Wednesday, June 10, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports...
While the combo showed a numerical improvement in progression-free survival, it did not reach statistical significance, and investigators said the probability o...
Merck (MRK) and Gilead Sciences (GILD) announced the discontinuation of the Phase 3 KEYNOTE-D46/EVOKE-03 study investigating Gilead’s Trodelvy in combination wi...
Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech By Thomas Richmond Published Jun 7, 9:30AM EDT Quick Read Merck's Keytr...
In late May 2026, Merck reported that its investigational KRAS G12C inhibitor calderasib (MK-1084), when combined with KEYTRUDA, received FDA Breakthrough Thera...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.